ArticleCancers2022

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study.

Saara Kuusisalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.